#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell small lymphocytic lymphoma refractory Alveolar proteinosis Pemphigus Mucopolysaccharidosis I Peritoneal neoplasm Cystic fibrosis Drug eruption Breast cancer metastatic HER2 gene amplification Pulmonary arterial hypertension Osteosarcoma metastatic Hepatocellular carcinoma Fibrodysplasia ossificans progressiva Progressive supranuclear palsy Arrhythmogenic right ventricular dysplasia More trials…

    Learn about Rare Diseases

    Hyperoxaluria – Treatment Myxofibrosarcoma – Basic Information Fragile X syndrome – Trials in Disease Prolymphocytic leukaemia – Diagnostics Myxofibrosarcoma – Diagnostics Systemic sclerosis pulmonary – Life with Disease Glomerulonephritis membranoproliferative – Trials in Disease Primary hyperoxaluria – Diagnostics Marginal zone lymphoma refractory – Trials in Disease Usher’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefazolin Tusamitamab Ravtansine Phenylephrine Hydrochloride Fidanacogene Elaparvovec Regn9933 Sym023 Bi 1839100 Sar444656 Tinengotinib Neflamapimod Vildagliptin Imipenem Monohydrate Dog Epithelium Extract ANHYDROUS CALCIUM FOLINATE Cevostamab GVV858 LTX-002 SODIUM Fenofibrate Micronised A/H1N1 INFLUENZA VACCINE Plerixafor More therapies…

    Learn about Your Condition

    Restless legs syndrome Hypomagnesaemia Reperfusion injury Spinal muscular atrophy Primary hypercholesterolaemia Pyelonephritis Primary adrenal insufficiency Vomiting Vulvar dysplasia Encephalitis autoimmune Breast cancer in situ Mixed-type liposarcoma Pancreatic carcinoma recurrent Abortion threatened Mastocytosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ireland

  • Adjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Divarasib
    • Nivolumab
    • Pembrolizumab
    Austria Belgium France Germany Greece Ireland +5
  • Efficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    Belgium Bulgaria Czechia France Germany Ireland +3
  • Study of BMS-986504 alone or in drug combination in adults with advanced or metastatic solid tumors with MTAP deletion

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • 2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE
    • Carboplatin
    • Cisplatin
    Belgium France Germany Ireland Italy Norway +1
  • Study of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Rmc-6291
    • (2S)-2-CYCLOPENTYL-2-[(5S)-2-[(2R,3R)-3-CYCLOPROPYL-1-METHYLAZIRIDINE-2-CARBONYL]-2,7-DIAZASPIRO[4.4]NONAN-7-YL]-N-[(6S,8S,14S)-21-[5-(4-CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-METHOXYETHYL]PYRIDIN-3-YL]-18,18-DIMETHYL-9,15-DIOXO-22-(2,2,2-TRIFLUOROETHYL)-5,16-DIOXA-2,10,22,28-TETRAZAPENTACYCLO[18.5.2.12,6.110,14.023,27]NONACOSA-1(26),20,23(27),24-TETRAEN-8-YL]ACETAMIDE
    • Ivonescimab
    Belgium France Germany Greece Ireland Italy +3
  • Venetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gemtuzumab Ozogamicin
    • Azacitidine
    • Cytarabine
    Austria Belgium Czechia Denmark Finland France +8
  • Phase 1/2 Study of CR-001 Safety and Dose Finding in Adults with Locally Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hepatobiliary cancer
    • Gastric cancer
    • Oesophageal adenocarcinoma
    France Ireland Italy Romania Spain
1 2 3 … 77
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Carboplatin Paclitaxel Cisplatin Dexamethasone Docetaxel Doxorubicin Hydrochloride Pemetrexed Sodium Chloride Gemcitabine Prednisolone Paclitaxel Albumin-Bound Cyclophosphamide Enzalutamide Paracetamol Nivolumab Bevacizumab Rituximab Hydrocortisone Etoposide Venetoclax Lenalidomide Anastrozole Capecitabine Oxaliplatin Fluorouracil Buclizine Hydrochloride Codeine Phosphate Letrozole Sacituzumab Tirumotecan Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

ABO haemolytic disease of newborn Acquired ATTR amyloidosis Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute myeloid leukaemia Addison's disease Adenocarcinoma gastric Adenocarcinoma pancreas Adrenogenital syndrome Alpha-1 antitrypsin deficiency Alveolar proteinosis Amyotrophic lateral sclerosis Anaemia Anaemia of pregnancy Anti-glomerular basement membrane disease Antiphospholipid antibodies Arteriosclerosis Asthma Autonomic nervous system imbalance B-cell small lymphocytic lymphoma B-cell small lymphocytic lymphoma recurrent B-cell small lymphocytic lymphoma refractory Barth syndrome Biliary neoplasm Bladder cancer Bladder cancer stage II Bladder cancer stage III Bladder transitional cell carcinoma Brain stem glioma Breast cancer Breast cancer female Breast cancer male Breast cancer metastatic Breast cancer recurrent Breast cancer stage I Breast cancer stage II Breast cancer stage III Bronchiectasis Bronchopulmonary dysplasia Cachexia Carcinoid syndrome Cardiac amyloidosis Cardiac failure Cardiomyopathy Cardiovascular disorder CDKL5 deficiency disorder Central nervous system neoplasm Cerebrovascular accident Cervix carcinoma Cervix carcinoma recurrent Cholangiocarcinoma Chondrosarcoma Choroid melanoma Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic left ventricular failure Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic obstructive pulmonary disease Clear cell renal cell carcinoma Clostridium difficile infection Coeliac disease Colitis ulcerative Colon cancer Colorectal cancer Colorectal cancer metastatic Coronary artery disease COVID-19 Critical illness Crohn's disease Cystic fibrosis Cystic fibrosis respiratory infection suppression Decreased appetite Dementia Alzheimer's type Dermatitis atopic Diffuse large B-cell lymphoma Drug dependence Dry age-related macular degeneration Duchenne muscular dystrophy Duchenne muscular dystrophy gene carrier Elderly Embolic stroke Embolism venous Emphysema Endometrial adenocarcinoma Endometrial cancer Endometrial cancer recurrent Ependymoma Epidermolysis bullosa Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Familial hypertriglyceridaemia Follicle centre lymphoma follicular grade I, II - III Follicular lymphoma Food allergy Fragile X syndrome Gastric cancer Gastrointestinal cancer metastatic Gastrooesophageal cancer Generalised tonic-clonic seizure Glioblastoma Glomerulonephritis membranous Haemolytic uraemic syndrome Haemophilia Hepatobiliary cancer Hepatoblastoma Hepatocellular carcinoma HER2 positive breast cancer Hereditary angioedema Hereditary angioedema with C1 esterase inhibitor deficiency Hereditary haemochromatosis Hidradenitis HIV infection Hodgkin's disease Homocystinuria Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Hot flush Huntington's disease Hypergammaglobulinaemia benign monoclonal Hypertension Hypertrophic cardiomyopathy Hypoxic-ischaemic encephalopathy Idiopathic inflammatory myopathy Idiopathic pulmonary fibrosis Immune thrombocytopenia Indolent systemic mastocytosis Interstitial lung disease Iron deficiency anaemia Juvenile idiopathic arthritis K-ras gene mutation Left ventricular dysfunction Lung disorder Lung neoplasm malignant Lymphatic malformation Major depression Malignant glioma Malignant melanoma Malignant neoplasm of choroid Malignant peritoneal neoplasm Mantle cell lymphoma Marginal zone lymphoma Mechanical ventilation Metabolic dysfunction-associated steatohepatitis Metastatic renal cell carcinoma Monkeypox Monkeypox immunisation Mucopolysaccharidosis II Myelodysplastic syndrome Myelodysplastic syndrome with excess blasts Myelofibrosis Myopia Myotonic dystrophy Neonatal alloimmune thrombocytopenia Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephrogenic anaemia Nephropathy Neuroblastoma Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer recurrent Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV NTRK gene fusion overexpression Obesity Oesophageal adenocarcinoma Oesophageal adenocarcinoma stage II Oesophageal adenocarcinoma stage III Oesophageal carcinoma Oesophageal squamous cell carcinoma Oesophageal squamous cell carcinoma stage II Oesophageal squamous cell carcinoma stage III Open angle glaucoma Oropharyngeal cancer Osteochondrodysplasia Osteogenesis imperfecta Osteosarcoma Ovarian cancer Ovarian cancer metastatic Ovarian cancer recurrent Ovarian cancer stage III Ovarian epithelial cancer Ovarian epithelial cancer recurrent Overweight Pancreatic carcinoma Pancreatic carcinoma metastatic Paroxysmal nocturnal haemoglobinuria Partial seizures Patent ductus arteriosus PD-L1 positive cancer Phenylketonuria PIK3CA related overgrowth spectrum PIK3CA-activated mutation Plasma cell myeloma Plasma cell myeloma refractory Pneumonia Polycythaemia vera Polyneuropathy Porphyria non-acute Post-traumatic stress disorder Postoperative wound infection Premature baby Primary amyloidosis Primary myelofibrosis Procedural pain Prostate cancer Prostate cancer metastatic Psoriatic arthropathy Pulmonary arterial hypertension Pulmonary fibrosis Rectal cancer Relapsing multiple sclerosis Renal cancer metastatic Renal cell carcinoma Renal cell carcinoma stage IV Respiratory tract infection Retinal artery occlusion Rhabdomyosarcoma Richter's syndrome Secondary progressive multiple sclerosis Serous cystadenocarcinoma ovary Sickle cell disease Sjogren's syndrome Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer recurrent Spinal muscular atrophy Squamous cell carcinoma Squamous cell carcinoma of head and neck Squamous cell carcinoma of lung Squamous cell carcinoma of skin Systemic lupus erythematosus Systemic mastocytosis Systemic scleroderma Testicular germ cell cancer Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Transitional cell carcinoma metastatic Transitional cell carcinoma urethra Triple negative breast cancer Type 2 diabetes mellitus Uveal melanoma Vascular malformation Von Willebrand's disease Waldenstrom's macroglobulinaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!